Literature DB >> 23263820

Quality and functionality of human ovarian tissue after cryopreservation using an original slow freezing procedure.

Sandra Sanfilippo1, Michel Canis, Sergio Romero, Benoît Sion, Pierre Déchelotte, Jean-Luc Pouly, Laurent Janny, Johan Smitz, Florence Brugnon.   

Abstract

PURPOSE: To evaluate the efficiency of an original slow freezing protocol on the quality and function of human ovarian cortex.
METHODS: Human ovarian tissues were cryopreserved using a freezing medium supplemented with propanediol and raffinose as cryoprotectants and antioxidants (L-glutamine, taurine). Samples were then frozen using a faster cooling rate than the usual one. Viability and morphology of follicles, DNA fragmentation in follicles and stroma as well as histology of the vascular endothelium were analyzed before and after freezing/thawing. Moreover, a functional analysis was performed based on the evaluation of follicular growth and development in thawed ovarian tissues that were cultured in vitro.
RESULTS: Our freezing/thawing protocol allows preservation of a high proportion of viable follicles and the preservation of the different follicle developmental stages (p>0.05 versus fresh control). 70.5 ± 5.2 % of follicles retained an intact morphology after cryopreservation (p=0.04). Stroma cells but not follicles exhibited a slight increase of DNA fragmentation after thawing (p<0.05). Microvessel endothelium within thawed tissues appeared to be preserved. Granulosa cells showed signs of proliferation in follicles cultured for 12 days. Secretion of 17β-oestradiol significantly increased during in vitro culture.
CONCLUSIONS: This protocol leads to good preservation of ovarian integrity and functionality post-thawing and thus appears as a suitable technique of ovarian tissue cryopreservation in clinical settings. Further research could be extended to optimize conditions of in vitro culture.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23263820      PMCID: PMC3553341          DOI: 10.1007/s10815-012-9917-5

Source DB:  PubMed          Journal:  J Assist Reprod Genet        ISSN: 1058-0468            Impact factor:   3.412


  51 in total

1.  In vitro follicle growth under non-attachment conditions and decreased FSH levels reduces Lhcgr expression in cumulus cells and promotes oocyte developmental competence.

Authors:  Flor Sánchez; Sergio Romero; Firas K Albuz; Johan Smitz
Journal:  J Assist Reprod Genet       Date:  2011-12-22       Impact factor: 3.412

2.  Islet cryopreservation: improved recovery following taurine pretreatment.

Authors:  A A Hardikar; M V Risbud; C Remacle; B Reusens; J J Hoet; R R Bhonde
Journal:  Cell Transplant       Date:  2001       Impact factor: 4.064

3.  Dynamics of follicular growth in the human: a model from preliminary results.

Authors:  A Gougeon
Journal:  Hum Reprod       Date:  1986-02       Impact factor: 6.918

4.  The effects of insulin, and insulin-like growth factors I and II on human ovarian follicles in long-term culture.

Authors:  H Louhio; O Hovatta; J Sjöberg; T Tuuri
Journal:  Mol Hum Reprod       Date:  2000-08       Impact factor: 4.025

5.  New natural inactivating mutations of the follicle-stimulating hormone receptor: correlations between receptor function and phenotype.

Authors:  P Touraine; I Beau; A Gougeon; G Meduri; A Desroches; C Pichard; M Detoeuf; B Paniel; M Prieur; J R Zorn; E Milgrom; F Kuttenn; M Misrahi
Journal:  Mol Endocrinol       Date:  1999-11

6.  Growth differentiation factor-9 promotes the growth, development, and survival of human ovarian follicles in organ culture.

Authors:  Julius Gisli Hreinsson; Jennifer E Scott; Carsten Rasmussen; Marja Liisa Swahn; Aaron J W Hsueh; Outi Hovatta
Journal:  J Clin Endocrinol Metab       Date:  2002-01       Impact factor: 5.958

7.  Morphological alterations and DNA fragmentation in oocytes from primordial and primary follicles after freezing-thawing of ovarian cortex in sheep.

Authors:  Banu Demirci; Bruno Salle; Lucien Frappart; Michel Franck; Jean François Guerin; Jacqueline Lornage
Journal:  Fertil Steril       Date:  2002-03       Impact factor: 7.329

8.  Follicular viability and morphology of sheep ovaries after exposure to cryoprotectant and cryopreservation with different freezing protocols.

Authors:  B Demirci; J Lornage; B Salle; L Frappart; M Franck; J F Guerin
Journal:  Fertil Steril       Date:  2001-04       Impact factor: 7.329

9.  Pregnancies and births after oocyte cryopreservation.

Authors:  Andrea Borini; Maria Antonietta Bonu; Giovanni Coticchio; Veronica Bianchi; Monica Cattoli; Carlo Flamigni
Journal:  Fertil Steril       Date:  2004-09       Impact factor: 7.329

10.  Parameters affecting successful transplantation of frozen-thawed human fetal ovaries into immunodeficient mice.

Authors:  Ronit Abir; Raoul Orvieto; Hila Raanani; Dov Feldberg; Shmuel Nitke; Benjamin Fisch
Journal:  Fertil Steril       Date:  2003-08       Impact factor: 7.329

View more
  15 in total

1.  Carbonyl cyanide 4-(trifluoromethoxy)phenylhydrazone (FCCP) pre-exposure ensures follicle integrity during in vitro culture of ovarian tissue but not during cryopreservation in the domestic cat model.

Authors:  Nae Tanpradit; Kaywalee Chatdarong; Pierre Comizzoli
Journal:  J Assist Reprod Genet       Date:  2016-09-17       Impact factor: 3.412

2.  Efficacy of ovarian tissue cryopreservation in a major European center.

Authors:  L Bastings; J Liebenthron; J R Westphal; C C M Beerendonk; H van der Ven; B Meinecke; M Montag; D D M Braat; R Peek
Journal:  J Assist Reprod Genet       Date:  2014-06-14       Impact factor: 3.412

3.  Glutamine and norepinephrine in follicular fluid synergistically enhance the antioxidant capacity of human granulosa cells and the outcome of IVF-ET.

Authors:  Lulu Wang; Chengliang Zhou; Junyan Sun; Qiuwan Zhang; Dongmei Lai
Journal:  Sci Rep       Date:  2022-06-15       Impact factor: 4.996

4.  Fresh and cryopreserved ovarian tissue from deceased young donors yields viable follicles.

Authors:  Yuting Fan; Colleen L Flanagan; Margaret A Brunette; Andrea S Jones; Brendon M Baker; Sherman J Silber; Ariella Shikanov
Journal:  F S Sci       Date:  2021-06-10

5.  Isoform 165 of vascular endothelial growth factor in collagen matrix improves ovine cryopreserved ovarian tissue revascularisation after xenotransplantation in mice.

Authors:  Laurie Henry; Soraya Labied; Maïté Fransolet; Nathalie Kirschvink; Silvia Blacher; Agnès Noel; Jean-Michel Foidart; Michelle Nisolle; Carine Munaut
Journal:  Reprod Biol Endocrinol       Date:  2015-03-07       Impact factor: 5.211

6.  Vitrification of human ovarian tissue: a practical and relevant alternative to slow freezing.

Authors:  Sandra Sanfilippo; Michel Canis; Johan Smitz; Benoît Sion; Claude Darcha; Laurent Janny; Florence Brugnon
Journal:  Reprod Biol Endocrinol       Date:  2015-06-25       Impact factor: 5.211

7.  Supplementation of transport and freezing media with anti-apoptotic drugs improves ovarian cortex survival.

Authors:  Laurie Henry; Maïté Fransolet; Soraya Labied; Silvia Blacher; Marie-Caroline Masereel; Jean-Michel Foidart; Agnès Noel; Michelle Nisolle; Carine Munaut
Journal:  J Ovarian Res       Date:  2016-02-12       Impact factor: 4.234

8.  Clinically applied procedures for human ovarian tissue cryopreservation result in different levels of efficacy and efficiency.

Authors:  Lobke Bastings; Johan R Westphal; Catharina C M Beerendonk; Ruud L M Bekkers; Petra L M Zusterzeel; Jan C M Hendriks; Didi D M Braat; Ronald Peek
Journal:  J Assist Reprod Genet       Date:  2016-10-06       Impact factor: 3.412

9.  Validation of an automated technique for ovarian cortex dissociation: isolation of viable ovarian cells and their qualification by multicolor flow cytometry.

Authors:  Tristan Zver; Elodie Mouloungui; Aurélie Berdin; Christophe Roux; Clotilde Amiot
Journal:  J Ovarian Res       Date:  2017-06-23       Impact factor: 4.234

Review 10.  Ovarian follicle culture: advances and challenges for human and nonhuman primates.

Authors:  Evelyn E Telfer; Mary B Zelinski
Journal:  Fertil Steril       Date:  2013-05       Impact factor: 7.329

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.